Joseph P. Slattery - 18 Dec 2025 Form 4 Insider Report for ImageneBio, Inc. (IKNA)

Reporting relationship: Director
Issuer ticker: IKNA
Reported as of: 18 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Dec 2025, 17:10:54 UTC
Prior SEC filing: 07 Nov 2025
Next SEC filing: 29 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Erin Butler, Attorney-in-Fact

Key filing fact

Joseph P. Slattery filed Form 4 for ImageneBio, Inc. (IKNA) on 22 Dec 2025.

Key facts

This page summarizes Joseph P. Slattery's Form 4 filing for ImageneBio, Inc. (IKNA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 Dec 2025, 17:10.

Change

Previous filing in this sequence was filed on 07 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001246530 Primary reporting owner

SLATTERY JOSEPH P

Relationship: Director
Address: C/O IMAGENEBIO, INC., 2526 HIGH BLUFF DRIVE, SAN DIEGO
Signature: /s/ Erin Butler, Attorney-in-Fact
Signature date: 22 Dec 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMA transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +31,200
Change %
Price: $0.000000
Shares after: 31,200
Date: 18 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 31,200
Exercise price: $6.19
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The award was granted as an Initial Grant as contemplated by the non-employee director compensation policy adopted by the Issuer's board of directors on December 18, 2025.

Footnote F2

This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in 36 substantially equal monthly installments, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan) through each such date.